FLT3 and acute myeloid leukemia: As these latter findings were based on an assay platform evaluating the dissociation constants of both compounds for selected kinases and disease relevant mutants, we were prompted to further functionally evaluate and compare the efficacy of EC-70124 and midostaurin against FLT3-ITDMUT AML cells.